Description
Cagrilintide
Research-Grade Amylin Analogue
Tagline: Appetite & Weight Regulation Research
Product Description
Cagrilintide is a long-acting amylin analogue designed for once-weekly administration in research models. It mimics the effects of endogenous amylin, a hormone co-secreted with insulin from pancreatic β-cells, and plays a key role in satiety signaling, gastric emptying regulation, and weight management.
Researchers use cagrilintide to investigate appetite control, energy balance, obesity treatment strategies, and combination therapies with GLP-1 receptor agonists.
For Laboratory and Scientific Research Use Only. Not for Human Consumption.
Why Researchers Choose Cagrilintide
-
Long-Acting Amylin Analogue: Engineered with prolonged half-life for sustained activity.
-
Appetite Suppression Studies: Potently reduces food intake in preclinical models.
-
Weight Regulation Research: Promotes negative energy balance and body fat reduction.
-
Combination Therapy Applications: Studied alongside semaglutide for additive metabolic effects.
-
Batch Verified: ≥98% purity, HPLC-tested for reproducibility.
Research Data & Handling Tips
-
Reconstitution: Reconstitute with sterile water or PBS; swirl gently until dissolved.
-
Solubility: Fully soluble in water and compatible buffers.
-
Storage: Store lyophilized powder at -20 °C; after reconstitution, aliquot and freeze at -80 °C.
-
Stability: Stable for 24 months (lyophilized); use within 4–8 weeks after reconstitution.
Important Note
For laboratory and scientific research only. Not for human consumption, therapeutic, or diagnostic use.
